Washington, D.C. — In a recent announcement, a research scientist at the University of Alabama at Birmingham, Dr. Jeanne Marrazzo, has been appointed as the new director of the National Institute of Allergy and Infectious Diseases. Dr. Marrazzo will be taking over from the renowned Dr. Anthony Fauci, who retired in December after an illustrious five-decade career. Dr. … [Read more...] about Dr. Jeanne Marrazzo to Succeed Dr. Anthony Fauci as Top Infectious Disease Expert
Global Invacom Group Expects Narrowed Net Loss and Increased Gross Profit in First Half
Global Invacom Group, a satellite company listed in Singapore and the U.K., announced that it anticipates reporting a reduced net loss and higher gross profit for the first half of the year. Despite a decline in revenue, the company's increased focus on product mix and implementation of efficiencies at its U.S. manufacturing facilities have contributed to these positive … [Read more...] about Global Invacom Group Expects Narrowed Net Loss and Increased Gross Profit in First Half
Shares of Azelis Group Fall as CEO Announces Retirement
By Andrea Figueras Shares in Azelis Group experienced a decline today after the company's Chief Executive Officer, Joachim Mueller, announced his retirement, effective at the end of this year. In addition, the company reported a decrease in net profit for the first half of the year. Leadership Changes and Appointments Azelis, a Belgium-based distributor of chemicals and food … [Read more...] about Shares of Azelis Group Fall as CEO Announces Retirement
EQB’s Shares Surge After Earnings Upgrade and Dividend Increase
Shares of EQB, the parent company of Canada's Equitable Bank, experienced a significant boost on Wednesday. This came after the company raised its earnings forecast for the year and increased its quarterly dividend by almost 3%, following a strong profit gain in the second quarter. In morning trading, EQB's shares rose by 6.5% to C$82.63, bringing their year-to-date advance to … [Read more...] about EQB’s Shares Surge After Earnings Upgrade and Dividend Increase
Merck KGaA Q2 2022 Results Preview
Merck KGaA is set to release its second-quarter results on Aug. 3, providing insights into the German health and technology company's performance. Let's take a look at the key details: Sales Forecast Consensus estimates from FactSet suggest that sales for the second quarter are expected to decline to 5.22 billion euros ($5.73 billion) from the previous year's EUR5.57 … [Read more...] about Merck KGaA Q2 2022 Results Preview
